Obesity is a complex, lifelong battle, and there's no quick fix! But is the medical community doing enough to help?
A recent statement from the Taiwan Medical Association for the Study of Obesity emphasizes that obesity is not a condition that can be cured with a single treatment. This declaration was made during the release of the 2025 Clinical Practice Guidelines on Adult Obesity in Taiwan at a joint event with the Japan-Korea-Taiwan Symposium on Obesity.
The association's president, Lin Wen-yuan, highlighted the World Health Organization's (WHO) stance on obesity, which classifies it as a chronic disease requiring comprehensive care. The WHO's latest guidelines also endorse the use of glucagon-like peptide-1 (GLP-1) therapies for long-term obesity treatment, but stress that medication alone is insufficient.
Here's the controversial part: The guidelines suggest that obesity should be defined not just by body mass index (BMI), but also by waist circumference, body composition, and metabolic risks. This broader definition allows for a more nuanced diagnosis, which is a significant shift.
The Taiwan guidelines offer a range of treatment options, including lifestyle changes, nutritional plans, physical activity, mental health support, medications (including GLP-1 therapies), endoscopic procedures, and surgery. They also provide tailored recommendations for various groups, such as the elderly and pregnant women, and emphasize patient-centric, empathetic care without stigmatization.
The WHO and Taiwan's guidelines differ slightly in their BMI classifications of obesity. The WHO defines obesity as a BMI of 30 or higher, while Taiwan's guidelines lower the threshold to 27 or above. This means that more people in Taiwan may be eligible for certain treatments, such as GLP-1 therapy, which is recommended for those with a BMI of 27 or higher and at least one related health condition.
However, the association has noted concerns about the misuse of GLP-1 therapies, including their use by non-obese individuals and excessive dosages, which can lead to health risks. This raises an important question: How can we ensure that these treatments are used responsibly and effectively?
The key message is clear: Obesity demands a holistic approach, and medical professionals play a crucial role in guiding patients toward sustainable health improvements. But what are your thoughts on the role of personal responsibility versus medical intervention in tackling obesity? Share your opinions below, and let's explore this multifaceted issue further.
